Mobile Health (mHealth) Technologies: Global Market Prospects - Featuring Expert Panel Views from Industry Survey 2017 |
Jun 1 2017 |
67 |
Global |
$2,995.00 |
|
Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline |
May 1 2017 |
69 |
Global |
$2,995.00 |
|
Asperger Syndrome Global Clinical Trials Review, H1, 2017 |
Apr 26 2017 |
53 |
Global |
$2,500.00 |
|
Articular Cartilage Defect Global Clinical Trials Review, H1, 2017 |
Apr 26 2017 |
61 |
Global |
$2,500.00 |
|
Artery Stenosis Global Clinical Trials Review, H1, 2017 |
Apr 26 2017 |
73 |
Global |
$2,500.00 |
|
Arteriosclerosis Global Clinical Trials Review, H1, 2017 |
Apr 26 2017 |
509 |
Global |
$2,500.00 |
|
Arterial Stiffness Global Clinical Trials Review, H1, 2017 |
Apr 26 2017 |
69 |
Global |
$2,500.00 |
|
Ascites Global Clinical Trials Review, H1, 2017 |
Apr 26 2017 |
87 |
Global |
$2,500.00 |
|
Arthralgia Global Clinical Trials Review, H1, 2017 |
Apr 26 2017 |
62 |
Global |
$2,500.00 |
|
Arteriovenous Fistula Global Clinical Trials Review, H1, 2017 |
Apr 26 2017 |
54 |
Global |
$2,500.00 |
|
Arterial Thrombosis Global Clinical Trials Review, H1, 2017 |
Apr 26 2017 |
54 |
Global |
$2,500.00 |
|
Arterial Calcification Global Clinical Trials Review, H1, 2017 |
Apr 26 2017 |
44 |
Global |
$2,500.00 |
|
PharmSource - M&A in the CMC Services Industry: Implications and Outlook |
Apr 11 2017 |
36 |
Global |
$2,995.00 |
|
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Spain |
Apr 11 2017 |
265 |
Spain |
$1,995.00 |
|
Partnerships, Licensing, Investments and M&A Deals and Trends for February 2017 in Pharmaceuticals |
Apr 6 2017 |
83 |
Global |
$1,000.00 |
|
Pharmaceutical Lifecycle Management Strategies in 2017 |
Apr 1 2017 |
82 |
Global |
$2,995.00 |
|
EpiCast Report: Cystic Fibrosis - Epidemiology Forecast to 2025 |
Apr 1 2017 |
73 |
Global |
$3,995.00 |
|
Age Related Memory Impairment Global Clinical Trials Review, H1, 2017 |
Mar 31 2017 |
43 |
Global |
$2,500.00 |
|
Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, H1, 2017 |
Mar 31 2017 |
67 |
Global |
$2,500.00 |
|
Amblyopia Global Clinical Trials Review, H1, 2017 |
Mar 31 2017 |
35 |
Global |
$2,500.00 |
|
Apnea of Prematurity Global Clinical Trials Review, H1, 2017 |
Mar 31 2017 |
46 |
Global |
$2,500.00 |
|
Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H1, 2017 |
Mar 31 2017 |
220 |
Global |
$2,500.00 |
|
Epidermolysis Bullosa Global Clinical Trials Review, H1, 2017 |
Mar 31 2017 |
67 |
Global |
$2,500.00 |
|
Aplastic Anemia Global Clinical Trials Review, H1, 2017 |
Mar 31 2017 |
167 |
Global |
$2,500.00 |
|
Ancylostomiasis (Hookworm Infections) Global Clinical Trials Review, H1, 2017 |
Mar 31 2017 |
50 |
Global |
$2,500.00 |
|
Alpha-Mannosidosis Global Clinical Trials Review, H1, 2017 |
Mar 31 2017 |
37 |
Global |
$2,500.00 |
|
Aphasia Global Clinical Trials Review, H1, 2017 |
Mar 31 2017 |
45 |
Global |
$2,500.00 |
|
Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2017 |
Mar 31 2017 |
75 |
Global |
$2,500.00 |
|
Alopecia Global Clinical Trials Review, H1, 2017 |
Mar 31 2017 |
163 |
Global |
$2,500.00 |
|
Aortic Aneurysm Global Clinical Trials Review, H1, 2017 |
Mar 31 2017 |
81 |
Global |
$2,500.00 |
|